D. Dixon

发表

Bayesian subset analysis.

R. Simon, D. Dixon, R. Simon, 1991, Biometrics.

A Bayesian model for evaluating specificity of treatment effects in clinical trials.

R. Simon, B. Freidlin, D. Dixon, 1995, Cancer treatment and research.

Bayesian subset analysis in a colorectal cancer clinical trial.

R. Simon, D. Dixon, R. Simon, 1992, Statistics in medicine.

Bayesian methods and ethics in a clinical trial design

D. Dixon, 1997 .

k-ratio t tests for multiple comparisons involving several treatments and a control.

D. B. Duncan, L. Brant, D. Dixon, 1992, Statistics in medicine.

Issues in the design and analysis of AIDS clinical trials.

J. Albert, D. Dixon, 1995, Cancer treatment and research.

Issues in regulatory guidelines for data monitoring committees

D. DeMets, R. Califf, B. Seto, 2004, Clinical trials.

The Society for Clinical Trials supports United States legislation mandating trials registration

K. Dickersin, Barry R Davis, B. Hawkins, 2004, Clinical trials.

Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees

C. Tangen, KyungMann Kim, R. Freedman, 2006, Clinical trials.

Data and Safety Monitoring

D. Dixon, L. Friedman, 2012 .

Strengthening biostatistics resources in sub‐Saharan Africa: Research collaborations through U.S. partnerships

J. Hogan, J. Neaton, V. DeGruttola, 2011, Statistics in medicine.

Should data and safety monitoring boards share confidential interim data?

S. Lagakos, D. Dixon, 2000, Controlled clinical trials.

Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials

D. Dixon, J. Mcnamara, K. Cahill, 2011, Clinical trials.

Commentary on Anand et al.

D. Dixon, 2011, Clinical trials.

Training of the next generation of biostatisticians: a call to action in the U.S.

Thomas A Louis, Dennis Dixon, Michael Boehnke, 2006, Statistics in medicine.

Intention to treat in clinical trials

Karl E. Peace, Dennis O. Dixon, Jay Herson, 1989 .

Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop.

J M Taylor, L A Kalish, J. Ioannidis, 1998, Statistics in medicine.

Statistical issues in designing clinical trials of aids treatments and vaccines

S. Ellenberg, D. Dixon, 1994 .

Sample size considerations for studies comparing survival curves using historical controls.

R Simon, R. Simon, D. Dixon, 1988, Journal of clinical epidemiology.

Minimum Bayes Risk t-Intervals for Multiple Comparisons

D. B. Duncan, D. Dixon, 1975 .

Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai District.

C. Grady, E. Emanuel, R. Gray, 2008, IRB.

Book Review: Bayesian approaches to clinical trials and health-care evaluation

D. Dixon, 2004 .

Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis.

J. Ioannidis, S. Bozzette, M. McIntosh, 1999, Controlled clinical trials.

NIAID Workshop, Memphis, Tennessee, 25-26 March 1997: Statistical issues for HIV surrogate endpoints: Point/counterpoint

John P. A. Ioannidis, Michael Hughes, Jeffrey M. Albert, 1998 .

Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials

Jonathan M. Kagan, Scott R. Rosas, D. Dixon, 2014, Clinical trials.

Should Sponsors and DSMBs Share Interim Results Across Trials?

Seema K. Shah, D. Dixon, R. Lie, 2011, Journal of acquired immune deficiency syndromes.

Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa

N. Morar, S. Hillier, D. Dixon, 2011, Clinical trials.

University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (afternoon panel session)

K. Dickersin, F. Ferris, S. Kimmel, 2018, Clinical trials.

k‐Ratio t Tests, t Intervals, and Point Estimates for Multiple Comparisons

D. B. Duncan, D. Dixon, 2006 .

Interval Estimates Derived from Bayes Testing Rules

D. Dixon, 1976 .

A bayes solution for the problem of ranking Poisson parameters

D. Dixon, R. P. Bland, 1971 .

HIV vaccine trials: some design issues including sample size calculation.

D. Dixon, P. Fast, W. Rida, 1993, Journal of acquired immune deficiency syndromes.